Justin Lee, MD
Interventional Cardiology · Hackensack, NJNPI 1588046684
Payments from drug & device makers
Across 185 payments — averaging $71.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abiomed$3K
- Boston Scientific$2K
- Abbott$1K
- Penumbra, Inc.$911
- Amgen$582
- plus $1K from 10 others
Across 5 payments — averaging $84.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Circulation Inc$220
- Abiomed$201
What the payments were for
- Grants$1,40211%
- Travel & lodging$3,60927%
- Food & beverage$8,21062%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 41 | $3,490 |
| Abiomed | 79 | $3,358 |
| Boston Scientific | 10 | $2,314 |
| Abbott | 22 | $1,283 |
| Penumbra, Inc. | 6 | $911 |
| Amgen | 9 | $582 |
| Shockwave Medical, Inc | 4 | $520 |
| Edwards Lifesciences | 1 | $179 |
| Coloplast | 2 | $156 |
| Cardiva Medical, Inc. | 2 | $140 |
| Stryker | 1 | $139 |
| GSK | 1 | $125 |
| Pfizer | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $23 |
| Irhythm Technologies, Inc. | 1 | $18 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONYX FRONTIER$2,264
- Impella$1,282
- GENERAL - STENTS$1,200
- Indigo System$852
- DRAGONFLY OPSTAR$531
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$520
- Repatha$368
- GENERAL CATHETER$202
- GENERAL VASCULAR ACCESS$186
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$179
- ROTAPRO$149
- AVVIGO Guidance System$147
- Emerge Push$145
- SYMPLICITY G3$139
- MAKO$139
- Isiris aStent Removal Device$134
- AREXVY$125
- XIENCE SIERRA$110
How this compares
$13,307 in reported general payments places this provider in the 60th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 110 | $107,891 |
| EntrestoSacubitril/Valsartan | 25 | $32,831 |
| XareltoRivaroxaban | 19 | $29,920 |
| Repatha SureclickEvolocumab | 25 | $20,575 |
| Praluent PenAlirocumab | 13 | $10,417 |
| FarxigaDapagliflozin Propanediol | 13 | $8,952 |
| Metoprolol Succinate | 185 | $4,000 |
| Atorvastatin Calcium | 154 | $2,327 |
| Olmesartan Medoxomil | 24 | $1,648 |
| ClopidogrelClopidogrel Bisulfate | 78 | $1,238 |
| Ranolazine ErRanolazine | 16 | $1,026 |
| Losartan Potassium | 52 | $958 |
| Amlodipine Besylate | 91 | $902 |
| Ezetimibe | 18 | $776 |
| Rosuvastatin Calcium | 46 | $741 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $52 | $107,891110 claims |
| NovartisEntresto | $14 | $32,83125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Hackensack
- Ryan KapleHackensack$280K
- Michael LimHackensack$231K
- Sung-Han YoonHackensack$105K
- Pranaychandra VaidyaHackensack$56K
- Hemal BhattHackensack$26K
- Dinesh SingalSomerset$1.4M
- Ankitkumar PatelGlen Ridge$717K
- Matthew SayboltEatontown$671K
- Jaffar RazaSecaucus$537K
- Kintur SanghviBordentown$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.